About
BRIVISSA (Brivaracetam) is an advanced antiepileptic drug (AED) primarily utilized in the treatment of partial-onset seizures, with or without secondary generalization, in patients aged 4 years and older. Its unique anticonvulsant mechanism involves the selective binding with high affinity to synaptic vesicle glycoprotein 2A (SV2A) in the brain. This specific interaction is thought to modulate the release of various neurotransmitters, particularly excitatory ones like glutamate, thereby stabilizing hyperexcitable neuronal membranes and effectively reducing the frequency and severity of seizure activity. Unlike some older AEDs, Brivaracetam exhibits a rapid onset of action and a favorable pharmacokinetic profile, characterized by linear pharmacokinetics and minimal drug-drug interactions, which simplifies its use in polytherapy. These attributes collectively make it a valuable and generally well-tolerated option in the comprehensive management of epilepsy, offering improved seizure control and contributing to a better quality of life for patients.
Uses
- Adjunctive treatment of partial-onset seizures.
- Monotherapy for partial-onset seizures.
- Management of epilepsy in adults.
- Treatment of epilepsy in pediatric patients (4 years and older).
Directions For Use
Take the tablet orally, usually twice daily, with or without food, as directed by your physician. Do not stop abruptly.
Benefits
- Effective in reducing seizure frequency.
- Well-tolerated by many patients.
- Rapid onset of action.
- Can be used as monotherapy or adjunctive therapy.
- Favorable pharmacokinetic profile.
- Improves seizure control and quality of life.
Side Effects
- Somnolence
- Dizziness
- Fatigue
- Nausea
- Vomiting
- Irritability
- Insomnia
- Headache
- Constipation
- Flu-like symptoms
- Mood changes
- Suicidal ideation (rare)
Safety Measures
- Alcohol - Avoid or limit alcohol consumption as it can increase central nervous system depression and exacerbate side effects like dizziness and drowsiness.
- Pregnancy - Use only if the potential benefit outweighs the risk to the fetus. Consult a doctor, as seizure control is crucial during pregnancy.
- Breastfeeding - Brivaracetam is excreted in human milk. A decision must be made whether to discontinue breastfeeding or discontinue the drug, considering the importance of the drug to the mother.
- Liver - Use with caution in patients with hepatic impairment; dose adjustment may be necessary. Close monitoring of liver function is recommended.
- Kidney - Use with caution in patients with severe renal impairment; dose adjustment may be required. No specific dose adjustment for mild to moderate impairment.
- Lung - Generally safe for use in patients with lung conditions. No specific contraindications or precautions related to respiratory function.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!